With advanced hepatobiliary oncology infrastructure, Herzliya Medical Center offers Cholangiocarcinoma Treatment for patients requiring specialised care for bile duct cancer. Established in 1983, the accredited hospital is located in Herzliya, Israel, and has 120 beds.

For selected patients with resectable disease, surgery may involve removal of the affected bile duct, part of the liver, or other nearby tissues, depending on tumour location. Advanced disease may require systemic treatment or palliative procedures such as biliary stenting. A multidisciplinary team evaluates imaging, pathology, tumour stage, and overall health before recommending treatment.